Project I-MOVE+

Duration: 2015-2018
Influenza: MOnitoring Vaccine effectiveness in Europe

Nivel-Logo-I-Move-Plus-250pxThe I-MOVE network aims to measure influenza vaccine effectiveness in Europe, in a way that is scientifically and financially independent from vaccine manufacturers. It publishes results immediately after the start of a seasonal epidemic or pandemic.



  • Full title: Influenza: MOnitoring Vaccine effectiveness in Europe
  • Deliverables: see publications on the right
  • Funding: European Commission
  • Project partners: 26 partners from 26 European countries
  • Nivel involvement: project partner
  • Nivel experts: Joke Korevaar PhD, Mariëtte Hooiveld PhD
  • International project website:

Meer wetenWhat can Nivel do for you?

For more information about Nivel as a partner in healthcare services research, please feel free to contact our manager International Projects Inge van Houdt PhD. We are looking forward tot get in touch with you.


Korevaar, J., Hooiveld, M. Project I-MOVE+. From: [Last update 14-April-2021; consulted on 16-April-2021]. URL: